Cerebellar Transcranial Direct Current Stimulation (tDCS) in Children with Autism Spectrum Disorder: Raynor Cerebellum Project
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Jan 17, 2023
Trial Information
Current as of May 08, 2025
Recruiting
Keywords
ClinConnect Summary
The Raynor Cerebellum Project is a research study looking at how a treatment called transcranial direct current stimulation (tDCS) can help children with Autism Spectrum Disorder (ASD) manage some of their challenges. This treatment involves using a gentle electrical current to stimulate specific areas of the brain, which researchers hope will improve certain skills and behaviors in children with ASD.
To participate in this study, children must be between the ages of 5 and 21 and have a confirmed diagnosis of autism from a doctor. However, some children may not be eligible, especially if they are pregnant, have brain implants or pacemakers, or have had significant brain injuries. If eligible, participants will receive tDCS treatment and may be asked to take part in assessments to track any changes. This study is currently recruiting participants, and all genders are welcome to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 5 to 21, male and female, with known autism spectrum disorder as diagnosed by a clinician
- Exclusion Criteria:
- • Pregnancy
- • Brain implants
- • Pacemakers
- • Any biomedical or metal implants in any part of body
- • Hearing or visual impairment
- • History of brain injury
- • Known brain or skull abnormality other than those that may be associated with ASD
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Dalls, Texas, United States
Patients applied
Trial Officials
Peter Tsai, MD, PhD
Principal Investigator
UT Southwestern Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials